Kawase, K.; Yoshida, K.; Hara, K.; Hidaka, S.; Takeyama, H. Efficacy and Safety of Neoadjuvant Chemotherapy With Dose De-Escalation Tri-Weekly Nanoparticle Albumin-Bound Paclitaxel and FEC for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Clinical Medicine Insights 2023, 4, 378-386.